Anesthesia News

Anesthesia

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Zimmer C et al. – Postherpetic neuralgia can lead to therapy–resistant neuropathic pain. The authors report the case of a 74–year–old woman with postherpetic perineal neuralgia resistant to opioids and antiepileptic drugs who has been successfully treated with oral ketamine for 28 months. Pain scores were reduced by more than 50%, despite dose reduction of other analgetic drugs. Significant side effects have not yet been reported. Despite “off–label” use, ketamine is an important third line option in cases of therapy–resistant neuropathic pain.

Related Articles

Tinnitus in postherpetic neuralgia
The Journal of Headache and Pain, 10/26/09    Relevance Score: 67%

Postherpetic Neuralgia: From Preclinical Models to the Clinic
Neurotherapeutics, 10/05/09    Relevance Score: 67%

The Effectiveness of Repetitive Paravertebral Injections with Local Anesthetics and Steroids for the Prevention of Postherpetic Neuralgia in Patients with Acute Herpes Zoster
Anesthesia & Analgesia, 10/21/09    Relevance Score: 66%

Treatment of Herpes Zoster and Postherpetic Neuralgia
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 10/19/09    Relevance Score: 66%

Granulocyte colony-stimulating factor for recalcitrant postherpetic neuralgia: a prospective, open, pilot study in three patients
Clinical and Experimental Dermatology, 10/01/09    Relevance Score: 65%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address